The ITN is currently seeking proposals for clinical trials for novel therapeutic approaches to induce B cell tolerance in patients who are donor-sensitized and/or to prevent sensitization. The therapeutic strategy must test specific immune mechanisms and must provide a clear pathway to future immune tolerance trials in solid organ transplantation.
Deadline: August 17, 2018.
Detailed information and instructions: RFP - Clinical trials for novel therapeutic approaches to induce B cell tolerance in patients who are donor-sensitized and/or to prevent sensitization.
Additional information about the ITN proposal submission process can be found here.
Please direct all proposal submissions and any questions concerning this RFP to Philip Bernstein, PhD, pbernstein@immunetolerance.org, (240) 235-6132.